Status quo und Zukunftsperspektiven der molekularen Diagnostik in der Dermatologie
Related Research units
Abstract
Molecular diagnostics (MDx) has become an indispensable pillar of diagnostics in dermatology. Modern sequencing technologies allow for identification of rare genodermatoses, analysis of somatic mutations in melanoma are prerequisite for targeted therapies, and cutaneous infectious pathogens are quickly detected by PCR and other amplification methods. However, to push innovation in molecular diagnostics and tackle so far unmet clinical needs, research activities need to be bundled and the pipeline from idea to MDx product clearly rolled out. Only then, the requirements for technical validity and clinical utility of novel biomarkers can be fulfilled and the long-term vision of personalized medicine will be realized.
Bibliographical data
Translated title of the contribution | Status quo and future perspectives of molecular diagnostics in dermatology |
---|---|
Original language | German |
ISSN | 1610-0379 |
DOIs | |
Publication status | Published - 04.2023 |
Comment Deanary
© 2023 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.
PubMed | 37070508 |
---|